Delivery Order SPE2DB20D1100-SPE2DB25FE5M7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57. This firm fixed price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 25, 2025, with completion scheduled for September 16, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, supports federal medical procurement needs through AmerisourceBergen's extensive pharmaceutical distribution network. The contractor will perform this delivery order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a contract value of $21,325.14. This non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and has established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $21,325.14 for the supply of Tagrisso 80 mg tablets (30-count packages). This is a firm fixed-price delivery order with no set-aside designation, issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets in a quantity of 30 units. This Firm Fixed Price delivery order carries a ceiling value of $10,662.57 and is scheduled for completion by August 18, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $31,987.71. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating that AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tagrisso 80 mg tablets (30-unit package). This contract represents a competitive, firm fixed-price procurement with no set-aside designation and a completion date of September 10, 2025. The award is executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition, reflecting the contractor's capability to meet federal procurement standards. The contract will be performed at AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Tagrisso 80 mg tablets (30-count units) with a contract ceiling value of $10,662.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 1, 2025, awarded on September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5M7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $53,312.85 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 9, 2025, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this prime vehicle and its associated delivery orders, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying medications to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.3k | 9/9/25 |